MV-012-968

MV-012-968 · Meissa Vaccines, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MV-012-968, covering 2022-08-04 to 2022-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine [Phase 2]